Practice

Clinical updates, guidelines, prescribing, and practical medicine

Biotech Industry Faces Political Uncertainty and AI Profitability Questions at BIO 2026

Biotech executives at BIO 2026 confronted mounting concerns over Chinese competition, the uncertain profitability of AI-driven drug discovery, and political…

Editor's Top Picks

Eli Lilly’s Obesity Drug Access: What We Know About FDA Approval Pathways

Regulatory pathways and corporate strategy shape early access to obesity drug candidates. Pharmaceutical acquisitions in the metabolic disease sector reflect…

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.

More form Practice

Creatine and Kidney Damage: What the Evidence Actually Shows

A 2025 systematic review of 21 studies and analysis of 685 clinical trials confirms that…

How neurotransmitters orchestrate mood, sleep, and cognition: a biochemical primer

Brain function depends on chemical communication between neurons through neurotransmitters. Twelve major neurotransmitter systems regulate…

What makes prostate cancer aggressive? Biology, genetics, and clinical grading explained

Prostate cancer aggressiveness is determined by histological grade (Gleason score), genetic mutations (PTEN loss, TP53,…

EMA Launches Email Notifications for Clinical Trial Information System

The European Medicines Agency has rolled out email notification subscriptions in CTIS, enabling clinical trial…